The Health Products Regulatory Authority (HPRA) has announced the recall of medicines containing the active ingredient valsartan, after possible contamination was detected at source.
The medications are manufactured at a Chinese facility.
The HPRA advises patients who regularly take this medicine to not stop taking it all of a sudden, and contact their pharmacist instead.
The recall may affect up to 50,000 patients in Ireland alone.